Enhancing Radium 223 Treatment Efficacy by Anti-Beta 1 Integrin Targeting

Scientists reported that targeting β1 integrin (β1I) significantly improved radium 223 outcome and points towards combinatorial application in prostate cancer tumors with high β1I expression.